Port
Vertex Pharmaceuticals Financial Results (VRTX)
Report publication dates, analyst consensus, and how Vertex Pharmaceuticals' share price reacted to previous earnings — all in one place, in English.
When Vertex Pharmaceuticals Reports Earnings
Vertex Pharmaceuticals' next earnings report is scheduled for November 2, 2026, according to the company's announcement.
The expected earnings per share (EPS) is -0.74 USD. Analyst forecasts range from -29.51 to 5.06 USD. The market reacts not to the absolute earnings figure, but to the difference between the actual result and this forecast.
Expected revenue: 3.42 B USD.
Vertex Pharmaceuticals' Latest Report: What the Numbers Showed
Vertex Pharmaceuticals' last published report covers the quarter ended June 30, 2026. Revenue was 3.33 billion USD, and net income was 1.10 billion USD. Earnings per share reached 4.73 USD compared to analysts' forecast of 4.75 USD — 0.32% below expectations. The share price changed by +0.34% in the first trading session after the release.
Insider Transactions: Vertex Pharmaceuticals
Who from the management board, supervisory board, US Congress, or government bought and sold shares of this company — based on official filings.
How the stock reacted to past earnings
The company beat analyst estimates in 50% of the last 4 quarters.
The average share price change on the day after earnings release is 1.98% — regardless of direction. The largest move was 6.55%. This number says more about the risk of holding a position through an earnings report than the earnings forecast itself.
| Quarter | Release date | EPS estimate | Actual EPS | Surprise | Share price reaction |
|---|---|---|---|---|---|
| June 30, 2026 | August 3, 2026 | 4.75 | 4.73 | -0.32% | +0.34% |
| March 31, 2026 | May 4, 2026 | 4.31 | 4.47 | +3.81% | +0.10% |
| December 31, 2025 | February 12, 2026 | 5.15 | 5.03 | -2.30% | +6.55% |
| September 30, 2025 | November 3, 2025 | 4.58 | 4.80 | +4.87% | -0.92% |
How much this company's stock moves after earnings
Vertex Pharmaceuticals' share price changes by an average of 1.98% on the first trading day after earnings releases — based on the last 4 reports, regardless of direction. This ranks 167 out of 180 companies for which we calculated this statistic.
Analyst forecasts for upcoming periods
The consensus is the average of many analysts' forecasts. The more analysts behind a number, the less likely it is to be a single error—but forecast agreement is never a guarantee of the actual result.
| Period | EPS estimate | EPS a year ago | Change | Revenue forecast | Analysts |
|---|---|---|---|---|---|
| Current quarter | -0.74 | 4.80 | -115.38% | $3.42 bn | 13 |
| Next quarter | 4.59 | 5.03 | -8.78% | $3.53 bn | 14 |
| Current year | 16.35 | 18.40 | -11.12% | $13.26 bn | 16 |
| Next year | 20.22 | 16.35 | +23.62% | $14.56 bn | 16 |
Revenue and margins quarter by quarter
Margin shows how much of sales a company retains. Rising revenue with shrinking margins means growth is coming at the expense of profitability—and that's usually more interesting than sales growth alone.
| Quarter | Revenue | Gross margin | Operating margin | Net margin |
|---|---|---|---|---|
| June 30, 2026 | $3.33 bn | 85.33% | 38.05% | 32.99% |
| March 31, 2026 | $2.99 bn | 86.85% | 38.13% | 34.53% |
| December 31, 2025 | $3.19 bn | 85.39% | 35.43% | 37.34% |
| September 30, 2025 | $3.08 bn | 86.52% | 40.27% | 35.20% |
| June 30, 2025 | $2.96 bn | 86.25% | 38.93% | 34.84% |
Who Reports in the Coming Weeks
Dates from the Portevo calendar — companies in the same industry are listed first, as their earnings often move the share prices of their peers even before their own reports.
About Vertex Pharmaceuticals
Vertex Pharmaceuticals Incorporated is listed on Nasdaq under the ticker VRTX and is headquartered in the United States. The company belongs to the Healthcare sector (industry: Biotechnology).
- Ticker: VRTX
- Exchange: Nasdaq
- Trading Currency: USD
- Sector: healthcare
- Number of Analysts Providing Estimates: 28
- 52-Week Range: 402.58 – 560.25
- Company website: https://www.vrtx.com
Frequently Asked Questions
When does Vertex Pharmaceuticals release earnings?
The next report is due on November 2, 2026.
What earnings did Vertex Pharmaceuticals report last quarter?
For the quarter ended June 30, 2026: revenue $3.33 billion, net income $1.10 billion, EPS $4.73. This is -0.32% compared to analyst forecasts.
What is Vertex Pharmaceuticals' ticker symbol?
VRTX — on Nasdaq. You may also see VRTX on trading platforms.
What is the EPS forecast for Vertex Pharmaceuticals?
The analyst consensus for the upcoming quarter is $ -0.74 per share. Individual forecasts range from $ -29.51 to $5.06.
How much does Vertex Pharmaceuticals' share price usually change after earnings?
On average, 1.98% in the session after publication, counting both directions. The largest recorded movement was 6.55%.
Does Vertex Pharmaceuticals usually beat analyst forecasts?
In the last 4 quarters, results exceeded forecasts in 50% of cases. History does not predict the next report, but it shows how cautiously analysts approach this company.
Where can I check Vertex Pharmaceuticals' financial results in English?
On Portevo — the earnings calendar, analyst forecasts, surprise history, and share price reactions are available for free and without an account.
Other companies in the healthcare sector
A company's earnings are most informative when compared to competitors in the same industry — this shows whether a weak quarter was a company-specific issue or a market-wide trend.
Related
Track Vertex Pharmaceuticals on Portevo
The company page in the app includes a price chart, indicators, and industry comparisons. Add a company to your watchlist, and its report will be highlighted in the earnings calendar—along with the rest of your portfolio.
Portevo is not an investment advisor. The data and analyses are for informational and educational purposes only and do not constitute a recommendation or an offer to buy or sell financial instruments. Quotes are from external providers and may be delayed. You make investment decisions at your own risk.
Your entire portfolio, company earnings, and insider trades in one place
Upload your XTB report or add companies manually — Portevo will calculate your net profit after costs, show you the earnings dates for your companies, and display insider faces on charts.
- Portfolio with Net Profit After Costs
- Earnings Calendar for Your Companies
- Pelosi, Trump, and CEO Trades on a Chart
- Works in Browser and on iPhone
No credit card required. A demo portfolio is available immediately; create your own by uploading a report.
